Rifapentine access in Europe: growing concerns over key tuberculosis treatment component

[No abstract available]Support statement: C. Lange is supported by the German Center of Infection Research (DZIF). All other authors have no funding to declare for this study. Funding information for this article has been deposited with the Crossref Funder Registry

Neurofibromatosis Type 1 (Nf1) and Pregnancy - Case With Positive Outcomes

Apregnancy is categorized as with high-risk when the life of the mother or the fetus becomes fragile due to various diseases. Many health problems can be manifested in women before pregnancy, during and after pregnancy. Some health problems can also begin in early adolescence with very light clinical signs, but during pregnancy because of the hormonal changes that may occur, lead to intensification of the disease. We report the management of a 26-year-old woman patient diagnosed with neurofibromatosis 1 (NF1), without any complications during pregnancy and childbirth